טוען...
Preclinical Dose Ranging Studies of a Novel Dry Powder Norovirus Vaccine Formulation
Norovirus is the primary cause of viral gastroenteritis in humans with multiple genotypes currently circulating worldwide. The development of a successful norovirus vaccine is contingent on its ability to induce both systemic and mucosal antibody responses against a wide range of norovirus genotypes...
שמור ב:
| הוצא לאור ב: | Vaccine |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4775331/ https://ncbi.nlm.nih.gov/pubmed/26873053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.01.064 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|